OUP user menu

View of statins as antimicrobials in cardiovascular risk modification

Emil Kozarov, Teresa Padro, Lina Badimon
DOI: http://dx.doi.org/10.1093/cvr/cvu058 First published online: 12 March 2014

Abstract

Atherosclerosis is a complex arterial pathological development underlying heart attack and stroke and a leading cause of death in developed and now also in developing countries. The primary processes that lead to the inflammatory lipid-laden proliferative lesion, obstructing the blood flow, and referred to as atherosclerotic plaque are dyslipidaemia and inflammation. Here, we will review one of the most efficient classes of drugs indicated for management of cardiovascular disease (CVD), statins. We will assess their pleiotropic effects that emerged from CVD applications, focusing this review specifically on plausible antimicrobial activity. Only recently gaining strength, the recognition of possible antibacterial activity may extend the statin applicability for vascular as well as to other critical inflammatory conditions.

  • Atherosclerosis
  • Statins
  • Microbial infection
  • Inflammation
View Full Text

Sign in

ESC members If your subscription is provided via the European Society of Cardiology, either as a member or an ESC Congress delegate, select the 'ESC Member and Congress Delegate Sign In' link in the list below. Discover if you are an ESC member here.

Otherwise, if your subscription is via OUP, enter your OUP username and password, or select an alternative sign in option below.

List of OpenAthens registered sites, including contact details.